passage bio stock price

Monday, July 18, 2022 Edit

This suggests a possible upside of 6870 from the stocks current price. Based on an average trading volume of 532200 shares the.

High Definition Microbiology Green Cells And Bacteria Under Microscope Stock Footage Microbiology Green High Bacteria Under Microscope Microbiology Bacteria

710a Airbnb stock price target cut to 120 from 160 at Stifel Nicolaus.

. Is followed by the analysts listed above. Get the latest Passage Bio stock price and detailed information including PASG news historical charts and realtime prices. Company profile page for Passage Bio Inc including stock price company news press releases executives board members and contact information.

View the latest Passage Bio Inc. Passage Bio Inc. The Company is focused on developing transformative therapies for central nervous system CNS disorders.

Common Stock PASG Stock Quotes - Nasdaq offers stock quotes market activity data for US and global markets. According to 15 analysts the average rating for PASG stock is Buy The 12-month stock price forecast is 1326 which is an increase of 43684 from the latest price. Passage Bio Inc a genetic medicines company develops transformative therapies for central nervous system diseases.

Their PASG stock forecasts range from 600 to 3400. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. Company facts information and financial ratios from MarketWatch.

Real-time trade and investing ideas on Passage Bio Inc PASG from the largest community of traders and investors. According to the issued ratings of 6 analysts in the last year the consensus rating for Passage Bio stock is Moderate Buy based on the current 2 hold ratings and 4 buy ratings for PASG. Changes and price drops for Passage Bio.

Find real-time PASG - Passage Bio Inc stock quotes company profile news and forecasts from CNN Business. Please note that any opinions estimates or forecasts regarding Passage Bio Incs performance made by these analysts are theirs alone and do not represent opinions forecasts or predictions of Passage Bio. On average they expect Passage Bios stock price to reach 1700 in the next twelve months.

Approximately 60 of the shares of the stock are short sold. Get the latest Passage Bio Inc PASG real-time quote historical performance charts and other financial information to help you make more informed trading and investment decisions. 5 Wall Street research analysts have issued 1-year price objectives for Passage Bios stock.

Get the latest Passage Bio Inc PASG detailed stock quotes stock data Real-Time ECN charts stats and more. PASG Stock Overview. PASG stock price quote stock graph news analysis.

Is a clinical stage genetic medicines company. 102 rows Discover historical prices for PASG stock on Yahoo Finance. The 12 analysts offering price forecasts for Passage Bio have a median target of 2433 with a high estimate of 4500 and a low estimate of 600.

PASG stock quote history news and other vital information to help you with your stock trading and investing. Learn about Passage Bio Inc Ordinary Shares PASGXNAS stock quote with Morningstars rating and analysis and stay up to date with the current news price valuation dividends and other stock. Find the latest Passage Bio Inc.

View daily weekly or monthly format back to when Passage Bio Inc. PASG stock price news historical charts analyst ratings and financial information from WSJ. Real time Passage Bio Inc.

A high-level overview of Passage Bio Inc. View Passage Bio Inc PASG investment stock information. Get Passage Bio Inc PASGNASDAQ real-time stock quotes news price and financial information from CNBC.

Its first product candidate PBGM01 utilizes a AAVhu68 capsid to deliver to the brain and peripheral tissues a functional. What are analysts forecasts for Passage Bio stock. NASDAQPASG - Get Rating was the recipient of a large drop in short interest in the month of June.

The average twelve-month price prediction for Passage Bio is 1700 with a high price target of 3400 and a low price target of 600. As of June 30th there was short interest totalling 1590000 shares a drop of 409 from the June 15th total of 2690000 shares.

Passage Bio Inc Investors And News Stock Information